|
Jun 27
|
Theralase(R) Extends Warrants
|
|
Jun 12
|
Theralase Completes Annual General and Special Meeting
|
|
May 20
|
Theralase Provides Corporate Update
|
|
Mar 16
|
Theralase Technologies Full Year 2024 Earnings: Beats Expectations
|
|
Mar 12
|
Theralase(R) Releases 2024 Annual Financial Statements
|
|
Mar 11
|
Theralase(R) Closes Non-Brokered Private Placement
|
|
Mar 10
|
Theralase(R) Therapy Improves Motor and Non-Motor Function in Parkinson's Patients
|
|
Feb 25
|
Theralase(R) Demonstrates Efficacy of Rutherrin(R) in Destruction of Non-Hodgkin's Lymphoma
|